Manuel Romero-Gómez
Manuel Romero-Gómez
Catedrático de Medicina, Universidad de Sevilla.
Verified email at - Homepage
TitleCited byYear
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
N Afdhal, S Zeuzem, P Kwo, M Chojkier, N Gitlin, M Puoti, ...
New England Journal of Medicine 370 (20), 1889-1898, 2014
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period
RJ Andrade, MI Lucena, MC Fernández, G Pelaez, K Pachkoria, ...
Gastroenterology 129 (2), 512-521, 2005
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
M Romero-Gómez, MDM Viloria, RJ Andrade, J Salmerón, M Diago, ...
Gastroenterology 128 (3), 636-641, 2005
Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis
E Vilar-Gomez, Y Martinez-Perez, L Calzadilla-Bertot, A Torres-Gonzalez, ...
Gastroenterology 149 (2), 367-378. e5, 2015
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment
JM Sánchez–Tapias, M Diago, P Escartín, J Enríquez, M Romero–Gómez, ...
Gastroenterology 131 (2), 451-460, 2006
Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy
M Romero-Gómez, F Boza, MS Garcıa-Valdecasas, E Garcıa, ...
The American journal of gastroenterology 96 (9), 2718-2723, 2001
Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ...
Gastroenterology 150 (5), 1147-1159. e5, 2016
HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis
JA Pineda, M Romero‐Gómez, F Díaz‐García, JA Girón‐González, ...
Hepatology 41 (4), 779-789, 2005
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles
MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ...
Gastroenterology 141 (1), 338-347, 2011
Value of the critical flicker frequency in patients with minimal hepatic encephalopathy
M Romero‐Gómez, J Córdoba, R Jover, JA Del Olmo, M Ramírez, R Rey, ...
Hepatology 45 (4), 879-885, 2007
Outcome of acute idiosyncratic drug‐induced liver injury: long‐term follow‐up in a hepatotoxicity registry
RJ Andrade, MI Lucena, N Kaplowitz, B García‐Muņoz, Y Borraz, ...
Hepatology 44 (6), 1581-1588, 2006
Phenotypic characterization of idiosyncratic drug‐induced liver injury: the influence of age and sex
MI Lucena, RJ Andrade, N Kaplowitz, M García‐Cortes, MC Fernández, ...
Hepatology 49 (6), 2001-2009, 2009
Interleukin‐28B genetic variants and hepatitis virus infection by different viral genotypes
MA Montes‐Cano, JR García‐Lozano, C Abad‐Molina, ...
Hepatology 52 (1), 33-37, 2010
Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines
C Randolph, R Hilsabeck, A Kato, P Kharbanda, YY Li, D Mapelli, ...
Liver international 29 (5), 629-635, 2009
Glutathione S‐transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug‐induced liver injury
MI Lucena, RJ Andrade, C Martínez, E Ulzurrun, E García‐Martín, ...
Hepatology 48 (2), 588-596, 2008
Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C
M Romero-Gómez, CM Fernández-Rodríguez, RJ Andrade, M Diago, ...
Journal of hepatology 48 (5), 721-727, 2008
Insulin resistance and hepatitis C
M Romero-Gómez
World journal of gastroenterology: WJG 12 (44), 7075, 2006
HLA class II genotype influences the type of liver injury in drug‐induced idiosyncratic liver disease
RJ Andrade, MI Lucena, A Alonso, M García‐Cort́es, E García‐Ruiz, ...
Hepatology 39 (6), 1603-1612, 2004
Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin
M Romero‐Gómez, M Diago, RJ Andrade, JL Calleja, J Salmerón, ...
Hepatology 50 (6), 1702-1708, 2009
Determinants of the clinical expression of amoxicillin‐clavulanate hepatotoxicity: a prospective series from Spain
MI Lucena, RJ Andrade, MC Fernández, K Pachkoria, G Pelaez, JA Durán, ...
Hepatology 44 (4), 850-856, 2006
The system can't perform the operation now. Try again later.
Articles 1–20